CELLDEX THERAPEUTICS, Inc. (CLDX) Misses Q3 EPS by 1c

November 2, 2011 7:07 AM
CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) reported Q3 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.01 million.

Categories

Earnings